539
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Design and development of liposomes for colon targeted drug delivery

, , &
Pages 146-160 | Received 17 Jul 2012, Accepted 24 Sep 2012, Published online: 01 Feb 2013

References

  • Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M. (2005). Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm, 305, 22–30.
  • Asghar LF, Chandran S. (2006). Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Pharm Sci, 9, 327–338.
  • Bradley PP, Priebat DA, Christensen RD, Rothstein G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol, 78, 206–209.
  • Camuesco D, Gálvez J, Nieto A, Comalada M, Rodríguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. (2005). Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr, 135, 687–694.
  • Chaud MV, Tamascia P, De Lima AC, Paganelli MO, Gremião MPD, De Freitas O. (2010). Solid dispersions with hydrogenated castor oil increase solubility, dissolution rate and intestinal absorption of praziquantel. Braz J Pharm Sci, 46, 473–481.
  • Gupta VK, Beckert TE, Price JC. (2001). A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm, 213, 83–91.
  • Hajj Hussein IA, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. (2008). Inflammatory bowel disease in rats: bacterial and chemical interaction. World J Gastroenterol, 14, 4028–4039.
  • http://MedicineNet.Com. Accessed on 4 September 2011.
  • Ibekwe VC, Kendall RA, Basit AW. (2004). Drug delivery to the colon. The drug delivery companies report spring/summer, 27–30.
  • Jubeh TT, Barenholz Y, Rubinstein A. (2004). Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm Res, 21, 447–453.
  • Karki R, Subramanya G, Udupa N. (2009). Formulation and evaluation of coencapsulated rifampicin and isoniazid liposomes using different lipids. Acta Pharmaceutica Sciencia, 51, 177–188.
  • Kirby C, Clarke J, Gregoriadis G. (1980). Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J, 186, 591–598.
  • Kogure K, Nakamura C, Okuda O, Hayashi K, Ueno M. (1997). Effect of dicetylphosphate or stearic acid on spontaneous transfer of protein from influenza virus-infected cells to dimyristoylphosphatidylcholine liposomes. Biochim Biophys Acta, 1329, 174–182.
  • Kumar M, Pathak K, Misra A. (2009). Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev Ind Pharm, 35, 387–395.
  • Lee HL, Mukherjee SK. (2006). Drug delivery-oral colon-specific. Encyclopedia of Pharmaceutical Technology. In: James S, ed. NY: Informa Health Care, 871–885.
  • Lee S, Lee J, Choi YW. (2007). Characterization and evaluation of freeze-dried liposomes loaded with ascorbyl palmitate enabling anti-aging therapy of the skin. Bull Korean Chem Soc, 28, 99–102.
  • Lu D, Hickey AJ. (2005). Liposomal dry powders as aerosols for pulmonary delivery of proteins. AAPS PharmSciTech, 6, E641–E648.
  • Marsanasco M, Marquez AI, Wagner OR, Alonso SD, Chiaramoni NS. (2011). Liposomes as vehicles for vitamins E and C: an alternative to fortify orange juice and offer vitamin C protection after heat treatment. Food Res Int, 44, 3039–3046.
  • Med DX, Alani AB, Robinson JR. (2005). Extended-release and targeted drug delivery systems. Remington-The Science and Practice of Pharmacy. New Delhi: B. I. Publications Pvt. Ltd., 939–963.
  • Misra A, Shah SP. (2004). Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance. AAPS PharmSciTech, 5, Article 65.
  • Naikwade S, Bajaj A. (2009). Preparation and in vitro evaluation of budesonide spray dried microparticles for pulmonary delivery. Sci Pharm, 77, 419–441.
  • Nounou MM, El-Khordagui LA, Khalafallah NA, Khalil SA. (2006). In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharm, 56, 311–324.
  • Philip AK, Philip B. (2010). Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J, 25, 79–87.
  • Riaz M. (1996). Liposomes preparation methods. Pak J Pharm Sci, 9, 65–77.
  • Sawant KK, Varia JK, Dodiya SS. (2008). Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization. Current Drug Deliv Rev, 5, 64–69.
  • Sener G, Aksoy H, Sehirli O, Yüksel M, Aral C, Gedik N, Cetinel S, Yegen BC. (2007). Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Dig Dis Sci, 52, 2122–2132.
  • Shaikh K, Pawar A. (2010). Liposomal delivery enhances cutaneous availability. Lat Am J Pharm, 29, 763–770.
  • Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, Nagarkatti PS. (2009). Resveratrol (trans-3,5,4′-trihydroxystilbene) induces SIRT1 and down-regulates NF-κB activation to abrogate DSS-induced colitis. J Pharmacol Exp Ther (In Press). DOI: 10.1124/jpet.109.160838.
  • Subrahmanyam CVS. (2000). Textbook of Physical Pharmaceutics. New Delhi, India: Vallabh Prakashan.
  • Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P. (2011). Development of novel budesonide pellets based on CODES™ technology: in vitro/in vivo evaluation in induced colitis in rats. Daru, 19, 107–117.
  • Vijayan V. (2010). Preparation and characterization of anti diabetic drug loaded solid lipid nanoparticles. JITPS, 1, 320–328.
  • Yang L. (2008). Biorelevant dissolution testing of colon-specific delivery systems activated by colonic microflora. J Control Release, 125, 77–86.
  • Yao J, Wang JY, Liu L, Zeng WS, Li YX, Xun AY, Zhao L, Jia CH, Feng JL, Wei XX, Wang LS. (2011). Polydatin ameliorates DSS-induced colitis in mice through inhibition of nuclear factor-κB activation. Planta Med, 77, 421–427.
  • Zhang P, Tu Y, Wang S, Wang Y, Xie Y, Li M, Jin Y. (2011). Preparation and characterization of budesonide loaded solid lipid nanoparticles for pulmonary delivery. J Chinese Pharm Sci, 1003–1057, 4-390-07, 390–396.
  • Zhang X, Liu J, Qiao H. (2010). Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Tech, 197, 120–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.